ARCA Biopharma Inc

Type: Company
Name: ARCA Biopharma Inc
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

ARCA Biopharma: An Undervalued Biotech With A Bright Future

By JMY Investments :I first wrote about Arca Biopharma ( ABIO ) in August, 2013, in the following article, Arca Biopharma Prepares For A Second Life . I considered the stock a value play and still do. Close to a year later, I thought it was a good time ... [Published BioPortfolio - Jul 03 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 1 reports

Arca biopharma Appoints Robert Conway as Chairman of Board [Professional Services Close - Up]

Arca biopharma said that Robert E. Conway has been elected Chairman of the Company's Board of Directors.Arca said he serves on the Audit and Compensation Committees of the Board of Directors.According to a company release, Conway has over 30 years of ... [Published Pharmacy Choice - Jun 17 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 1 reports

Robert E. Conway Elected Chairman of ARCA biopharma Board of Directors

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that Robert E. Conway, has been elected Chairman of the Company's ... [Published FierceBiotech - Jun 13 2014]
First reported Jun 10 2014 - Updated Jun 10 2014 - 1 reports

ARCA BIOPHARMA, INC. FILES (8-K) Disclosing Submission of Ma. . .

Item 5.07 Submission of Matters to a Vote of Security HoldersOn June 5, 2014, the Company held it's 2014 Annual Meeting of Stockholders (the "2014 Annual Meeting") at which the Company's stockholders voted upon (i) the election of Company nominees Dr. ... [Published Equities.com - Jun 10 2014]
First reported Jun 09 2014 - Updated Jun 09 2014 - 1 reports

ARCA biopharma Inc elects chairman

1:30pm BSTARCA biopharma Inc:Says Robert E. Conway, has been elected chairman of the company's board of directors. ... [Published Reuters UK - Jun 09 2014]
First reported Jun 05 2014 - Updated Jun 05 2014 - 1 reports

ARCA BIOPHARMA : Assigned Patent

By Targeted News ServiceALEXANDRIA, Va. , June 4 -- Arca Biopharma , Broomfield, Colorado , has been assigned a patent (8,715,941) developed by two co-inventors for "[a]ntibodies to LRP6." The co-inventors are Arie Abo , Oakland, California , and Minke ... [Published 4 Traders - Jun 05 2014]
First reported May 29 2014 - Updated May 29 2014 - 1 reports

5 Stocks Under $10 Set to Soar

 Delafield, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline ... [Published The Street Latest - May 29 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

ARCA biopharma to Present at the Growth Capital Expo 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA to present at Growth Capital Expo 2014 investor conference being held April 29 - May 1, 2014. ... [Published Business Wire Health News - Apr 22 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 3 reports

ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

ARCA biopharma Files Shelf Registration Statement

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has filed a universal shelf registration statement with ... [Published Business Wire Health News - Apr 04 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 12:05 pm MDT / 2:05pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba ... [Published Marketwire - Breaking News Releases - Mar 19 2014]
Entities: ARCA Biopharma Inc
First reported Feb 12 2014 - Updated Feb 12 2014 - 2 reports

ARCA adds to board of directors

ARCA biopharma has appointed Dan Mitchell to its board of directors. Mitchell is a manager of Sequel Venture Partners , which he founded. Based in Colorado, ARCA is a biopharmaceutical company focused on cardiovascular diseases. PRESS RELEASE WESTMINSTER, ... [Published PE Hub Blog - Feb 12 2014]

Quotes

"Bob's experience and leadership are a tremendous asset to Arca," said Dr. Michael R Bristow, President and Chief Executive Officer of Arca. "With his significant experience in leading both drug development efforts and companies in the biopharmaceutical sector, Bob's input and guidance be valuable to the Arca Board as we continue the development of Gencaro and look to deliver value to our stockholders."
(d) Exhibits. Exhibit Number Description 99.1 Press Release titled "Robert E Conway Elected Chairman of ARCAARCA biopharma Board of Directors" dated June 9, 2
..." Giroux said he has been commanded to "take the investigation any direction it goes involving criminality in the mayor or the mayor's office." ( http://link.reuters.com/nyx56v )

More Content

All (24) | News (12) | Reports (0) | Blogs (11) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
ARCA Biopharma: An Undervalued Biotech With A B... [Published BioPortfolio - Jul 03 2014]
Arca biopharma Appoints Robert Conway as Chairm... [Published Pharmacy Choice - Jun 17 2014]
Robert E. Conway Elected Chairman of ARCA bioph... [Published FierceBiotech - Jun 13 2014]
ARCA BIOPHARMA, INC. FILES (8-K) Disclosing Sub... [Published Equities.com - Jun 10 2014]
ARCA biopharma Inc elects chairman [Published Reuters UK - Jun 09 2014]
ARCA BIOPHARMA : Assigned Patent [Published 4 Traders - Jun 05 2014]
5 Stocks Under $10 Set to Soar [Published The Street Latest - May 29 2014]
ARCA biopharma to Present at the Growth Capital... [Published Business Wire Health News - Apr 22 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Health News - Apr 17 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire News with Multimedia - Apr 17 2014]
ARCA biopharma Files Shelf Registration Statement [Published Business Wire Health News - Apr 04 2014]
ARCA biopharma CEO Michael R. Bristow to Be Int... [Published Marketwire - Breaking News Releases - Mar 19 2014]
Small-Cap Biotech on the Verge of a Breakout: ABIO [Published The Street Latest - Mar 12 2014]
Top Gainers Technical Data: Ocean Power Technol... [Published Financial Services - Mar 12 2014]
4 Biotech Stocks Under $10 Moving Higher [Published The Street Latest - Feb 26 2014]
ARCA adds to board of directors [Published PE Hub Blog - Feb 12 2014]
Dan Mitchell Joins ARCA biopharma Board of Dire... [Published Business Wire Health News - Feb 12 2014]
5 Stocks Insiders Love Right Now [Published The Street Latest - Feb 05 2014]
Top Insider Trades: PSX YRCW CRTX IDIX [Published The Street Latest - Feb 05 2014]
ARCA biopharma Announces Pricing of $9 Million ... [Published Business Wire Health News - Feb 04 2014]
Frontrunning: February 4 [Published Zero Hedge - Feb 04 2014]
ARCA biopharma Announces Proposed Public Offeri... [Published Business Wire Health News - Feb 03 2014]
ARCA, DCRI enter clinical trial agreement for G... [Published Pharmaceutical Business Review - Nov 08 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ARCA biopharma to Present at the Growth Capital... [Published Business Wire Health News - Apr 22 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA to present at Growth Capital Expo 2014 investor conference being held April 29 - May 1, 2014. ...
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ...
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Health News - Apr 17 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ...
ARCA biopharma Announces Screening of First Pat... [Published Business Wire News with Multimedia - Apr 17 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ...
ARCA biopharma Files Shelf Registration Statement [Published Business Wire Health News - Apr 04 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has filed a universal shelf registration statement with ...
1 2 3

Press Releases

sort by: Date | Relevance
Top Gainers Technical Data: Ocean Power Technol... [Published Financial Services - Mar 12 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.